Seres Therapeutics Inc (MCRB)

Jul 25, 2025

Is Seres Therapeutics Inc. a good long term investmentRapid profit acceleration - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Will Seres Therapeutics Inc. stock benefit from AI tech trendsHigh-yield capital appreciation - jammulinksnews.com

Jul 25, 2025

Jul 25, 2025

What risks could impact Seres Therapeutics Inc. stock performancePhenomenal capital appreciation - jammulinksnews.com

Jul 25, 2025

Jul 25, 2025

What analysts say about Seres Therapeutics Inc. stockFree Stock Market Beginners Guide - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Why Seres Therapeutics Inc. stock is on top investor watchlistsHigh-yield capital appreciation - jammulinksnews.com

Jul 25, 2025

Jul 25, 2025

What institutions are buying Seres Therapeutics Inc. stock nowBreakneck growth rates - jammulinksnews.com

Jul 25, 2025

Jul 24, 2025

What drives Seres Therapeutics Inc. stock priceUnprecedented growth rates - Autocar Professional

Jul 24, 2025

Jul 23, 2025

Seres Therapeutics Inc. Stock Analysis and ForecastFree Consultation - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Seres Therapeutics announces leadership transition - MSN

Jul 23, 2025

Jul 23, 2025

Seres Therapeutics Soars 10.98% on Leadership Transition - AInvest

Jul 23, 2025

Jul 22, 2025

Seres Therapeutics stock jumps after naming co-CEOs By Investing.com - Investing.com Canada

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics (MCRB) Announces Transition in Executive Lead - GuruFocus

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics Announces Leadership Transition - The Manila Times

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025 - The Manila Times

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics to Host Conference Call on August 6, 2025, to Discuss Q2 Financial Results and Business Updates - Quiver Quantitative

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics Appoints Dual CEOs, Explores Deals as Breakthrough Drug Shows Promising Results - Stock Titan

Jul 22, 2025

Jul 21, 2025

Seres Therapeutics, Inc.'s (NASDAQ:MCRB) top owners are individual investors with 51% stake, while 23% is held by institutions - Yahoo Finance

Jul 21, 2025

Jul 20, 2025

individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase in their holdings value last week - simplywall.st

Jul 20, 2025

Jul 18, 2025

what makes seres therapeutics inc. stock price move sharplyChart Breakout Alert - Newser

Jul 18, 2025

Jul 18, 2025

How high can Seres Therapeutics Inc. stock price go in 2025Protected Capital Trading Plan - Newser

Jul 18, 2025

Jul 15, 2025

What makes Seres Therapeutics Inc. stock price move sharplyFree Trading Group - Newser

Jul 15, 2025

Jul 15, 2025

How Seres Therapeutics Inc. stock performs during market volatilityWatchlist Winner Update - Newser

Jul 15, 2025

Jul 15, 2025

Why Seres Therapeutics Inc. stock attracts strong analyst attentionFree Smart Money Group - Newser

Jul 15, 2025

Jul 14, 2025

Seres Therapeutics Soars 21%—What’s Fueling the Biotech Breakout? - AInvest

Jul 14, 2025

Jul 01, 2025

5 Best Microbiome Companies (July 2025) - Securities.io

Jul 01, 2025

Jun 30, 2025

Seres Therapeutics, Inc.(NasdaqGS: MCRB) added to Russell 3000E Index - MarketScreener

Jun 30, 2025

Jun 30, 2025

Seres Therapeutics, Inc.(NasdaqGS: MCRB) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025

Jun 25, 2025

Seres Therapeutics May 2025 slides: SER-155 shows 77% infection reduction in transplant patients - Investing.com Nigeria

Jun 25, 2025

Jun 12, 2025

FMR LLC Reduces Stake in Seres Therapeutics Inc: A Strategic Rea - GuruFocus

Jun 12, 2025

Jun 02, 2025

Denodo University Challenge Now Open: Data and AI for Real-World Impact - GlobeNewswire Inc.

Jun 02, 2025

May 28, 2025

Seres Therapeutics, Inc. (NASDAQ:MCRB) Given Consensus Recommendation of “Reduce” by Brokerages - Defense World

May 28, 2025